Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manjunath P Pai

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2021
Validity of 2020 vancomycin consensus recommendations and further guidance for practical applicationMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2020
Questions on Vancomycin DosingMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
BMC Infectious Diseases|August 3, 2017
Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot studyDmitriy M Martirosov, Monique R Bidell, Manjunath P Pai, et al.
The Journal of Trauma and Acute Care Surgery|June 14, 2023
Prolonging the therapeutic window for valproic acid treatment in a swine model of traumatic brain injury and hemorrhagic shockGuang Jin, Jessie W Ho, Toby Philip Keeney-Bonthrone, et al.
Leukemia & Lymphoma|March 8, 2021
Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in miceKarthik Ravi, Andrea Franson, Morgan J Homan, et al.
Elife|December 1, 2020
An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogenValerie J Morley, Clare L Kinnear, Derek G Sim, et al.
Pharmacotherapy|July 30, 2024
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infectionsKatie B Olney, Manjunath P Pai, Jenni K Thomas, et al.
Pharmacotherapy|September 20, 2023
Morphomics-informed population pharmacokinetic and physiologically-based pharmacokinetic modeling to optimize cefazolin surgical prophylaxisShuhan Liu, Aleksas Matvekas, Tamara Naimi, et al.
The Journal of Trauma and Acute Care Surgery|November 24, 2020
Administration of valproic acid in clinically approved dose improves neurologic recovery and decreases brain lesion size in swine subjected to hemorrhagic shock and traumatic brain injuryGlenn K Wakam, Ben E Biesterveld, Manjunath P Pai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral NeuropathyDaniel L Hertz, Kelley M Kidwell, Kiran Vangipuram, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2021
Validity of 2020 vancomycin consensus recommendations and further guidance for practical applicationMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2020
Questions on Vancomycin DosingMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
BMC Infectious Diseases|August 3, 2017
Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot studyDmitriy M Martirosov, Monique R Bidell, Manjunath P Pai, et al.
The Journal of Trauma and Acute Care Surgery|June 14, 2023
Prolonging the therapeutic window for valproic acid treatment in a swine model of traumatic brain injury and hemorrhagic shockGuang Jin, Jessie W Ho, Toby Philip Keeney-Bonthrone, et al.
Leukemia & Lymphoma|March 8, 2021
Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in miceKarthik Ravi, Andrea Franson, Morgan J Homan, et al.
Elife|December 1, 2020
An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogenValerie J Morley, Clare L Kinnear, Derek G Sim, et al.
Pharmacotherapy|July 30, 2024
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infectionsKatie B Olney, Manjunath P Pai, Jenni K Thomas, et al.
Pharmacotherapy|September 20, 2023
Morphomics-informed population pharmacokinetic and physiologically-based pharmacokinetic modeling to optimize cefazolin surgical prophylaxisShuhan Liu, Aleksas Matvekas, Tamara Naimi, et al.
The Journal of Trauma and Acute Care Surgery|November 24, 2020
Administration of valproic acid in clinically approved dose improves neurologic recovery and decreases brain lesion size in swine subjected to hemorrhagic shock and traumatic brain injuryGlenn K Wakam, Ben E Biesterveld, Manjunath P Pai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral NeuropathyDaniel L Hertz, Kelley M Kidwell, Kiran Vangipuram, et al.
Pageof 19